Skip to main content

Weill Cornell Medicine has received a four-year, $8.2 million grant from the National Institute of Child Health and Human Development (NICHD) to develop and test an experimental on-demand male contraceptive pill that temporarily stops sperm in their tracks. Dr. Jochen Buck and Lonny Levin ’83, both professors of pharmacology at Weill Cornell, are leading the project to help fill an urgent global need for new contraceptive options for men.

Currently, about half of all pregnancies worldwide are unplanned, and contraceptive options for men have been limited to condoms and vasectomies. As a result, the burden of contraception largely falls to women, who often rely on long-term use of hormonal contraceptives, which may have a variety of side effects, Levin said.

“We’ve developed an on-demand contraceptive pill that men would take 30 minutes before having sex,” said Buck. “The pill provides a six-to-eight-hour window of protection from pregnancy, and afterwards, fertility returns to normal. The grant will enable us to conduct the toxicology and safety studies needed to demonstrate the drug is safe for use in humans.”

Get the news here.